Skip to main content
. 2020 Nov 13;10:579327. doi: 10.3389/fonc.2020.579327

Table 3.

Proportion of CDKN2A homozygous loss according to malignant pleural mesothelioma (MPM) subtype.

MPM Subtype CDKN2A Homozygous Loss
Epithelioid 68% (19/28)
Sarcomatoid 71% (5/7)
Biphasic 95% (20/21)
Total cases homozygous loss analysed by FISH 78% (44/56)